This workshop offers an in-depth exploration of the evolving landscape of pharmacovigilance across the MENA region, with a special focus on regulatory updates, advanced technologies, and critical healthcare challenges. Bringing together industry experts and regulators, the event will feature discussions on the latest regulatory updates in pharmacovigilance, developments in orphan drugs and the use of AI and technology in pharmacovigilance.

Key sessions will cover this:

Regional Regulatory Updates: Focused on recent advancements in pharmacovigilance regulations in Algeria, Egypt and others, this session will outline how these changes are enhancing safety monitoring and compliance.
Orphan Drugs: This interactive and collaborative session will address the unique pharmacovigilance challenges posed by orphan drugs. Together, we’ll explore the roles of industry and regulators in improving access and enhancing synergies between these sectors, using a real-world business case as our foundation.
AI and Technology in Pharmacovigilance: This session will dive into how AI and data analytics are being utilized across the MENA region to enhance drug safety monitoring and optimize pharmacovigilance processes.

In addition to expert-led presentations, the workshop will provide ample opportunities for networking, fostering collaboration between regulators and industry professionals. This will be an ideal platform for exchanging knowledge, sharing best practices, and discussing future trends in pharmacovigilance within the region.